{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:54:54Z","timestamp":1761540894590},"reference-count":93,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.4065\/81.5.679","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:27:47Z","timestamp":1232760467000},"page":"679-691","source":"Crossref","is-referenced-by-count":20,"title":["A Practical Approach to Genetic Testing for von Willebrand Disease"],"prefix":"10.4065","volume":"81","author":[{"given":"Rajiv K.","family":"Pruthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/81.5.679_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4065\/81.5.679_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1615780","article-title":"Biochemistry and physiology of blood coagulation","volume":"82","author":"Mann","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4065\/77.8.773","article-title":"Primer on medical genomics, part I: history of genetics and sequencing of the human genome","volume":"77","author":"Lorentz","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/81.5.679_bib4","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.4065\/81.5.679_bib5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.1995.00430130095010","article-title":"Usefulness of patient interview in bleeding disorders","volume":"155","author":"Sramek","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.4065\/81.5.679_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"10.4065\/81.5.679_bib7","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.4065\/81.5.679_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/beha.2001.0133","article-title":"Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation","volume":"14","author":"Ruggeri","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/81.5.679_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.56.082103.104713","article-title":"New concepts in von Willebrand disease","volume":"56","author":"Sadler","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.4065\/81.5.679_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0954-6820.1977.tb15737.x","article-title":"Von Willebrand's disease\u2014fifty years old","volume":"201","author":"Nilsson","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.4065\/81.5.679_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.4065\/81.5.679_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJM198207083070221","article-title":"Incidence of severe von Willebrand's disease [letter]","volume":"307","author":"Weiss","year":"1982","journal-title":"N Engl J Med"},{"key":"10.4065\/81.5.679_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2141.1984.tb02876.x","article-title":"Atherosclerosis and von Willebrand factor, I: prevalence of severe von Willebrand's disease in western Europe and Israel","volume":"57","author":"Mannucci","year":"1984","journal-title":"Br J Haematol"},{"key":"10.4065\/81.5.679_bib15","first-page":"7","article-title":"Heredit\u00e4r pseudohemofili","volume":"5","author":"von Willebrand","year":"1926","journal-title":"Finska Lakaresallsk Handl"},{"key":"10.4065\/81.5.679_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/bmj.3.5822.317","article-title":"Genetic variants of von Willebrand's disease","volume":"3","author":"Holmberg","year":"1972","journal-title":"Br Med J"},{"key":"10.4065\/81.5.679_bib17","series-title":"Thrombosis and Haemostasis","first-page":"419","article-title":"Classification of von Willebrand disease","author":"Ruggeri","year":"1987"},{"key":"10.4065\/81.5.679_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/beha.2001.0134","article-title":"A molecular approach to the classification of von Willebrand disease","volume":"14","author":"Schneppenheim","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/81.5.679_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/beha.2001.0135","article-title":"Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder","volume":"14","author":"Favaloro","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/81.5.679_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2004.00894.x","article-title":"The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization","volume":"10","author":"Laffan","year":"2004","journal-title":"Haemophilia"},{"key":"10.4065\/81.5.679_bib22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1538-7836.2004.00693.x","article-title":"Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients [published correction appears in J Thromb Haemost. 2005;3:622]","volume":"2","author":"Quiroga","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.4065\/81.5.679_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1538-7836.2005.01245.x","article-title":"Provisional criteria for the diagnosis of VWD type 1","volume":"3","author":"Sadler","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.4065\/81.5.679_bib24","first-page":"863","article-title":"Assays for von Willebrand factor functional activity: a UK NEQAS survey [letter] [published correction appears in Thromb Haemost. 1999;81:478]","volume":"80","author":"Preston","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2002.03199.x","article-title":"Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay","volume":"116","author":"Riddell","year":"2002","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"10.4065\/81.5.679_bib26","volume":"3","author":"Federici","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.4065\/81.5.679_bib27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0037-1616211","article-title":"Getting at the variable expressivity of von Willebrand disease","volume":"86","author":"Levy","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib29","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib30","first-page":"89","article-title":"Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.4065\/81.5.679_bib31","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib32","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1172\/JCI108432","article-title":"The effects of epinephrine infusion in patients with von Willebrand's disease","volume":"57","author":"Rickles","year":"1976","journal-title":"J Clin Invest"},{"key":"10.4065\/81.5.679_bib33","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0025-6196(12)61202-6","article-title":"Laboratory diagnosis of von Willebrand's disease","volume":"66","author":"Triplett","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/81.5.679_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ajcp\/104.3.264","article-title":"Laboratory assessment of von Willebrand factor: use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms","volume":"104","author":"Favaloro","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/81.5.679_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1096-8652(200101)66:1<53::AID-AJH1009>3.0.CO;2-I","article-title":"Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor","volume":"66","author":"Favaloro","year":"2001","journal-title":"Am J Hematol"},{"key":"10.4065\/81.5.679_bib36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1365-2141.2000.01944.x","article-title":"Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect","volume":"108","author":"Castaman","year":"2000","journal-title":"Br J Haematol"},{"key":"10.4065\/81.5.679_bib37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand's disease: variability versus \u201cvariants\u201d","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00062752-200109000-00007","article-title":"Diagnosis and incidence of inherited von Willebrand disease","volume":"8","author":"Hambleton","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.4065\/81.5.679_bib39","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood.V74.6.1997.1997","article-title":"Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A","volume":"74","author":"Rodeghiero","year":"1989","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1981.tb02789.x","article-title":"Response of factor VIII\/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease","volume":"47","author":"Mannucci","year":"1981","journal-title":"Br J Haematol"},{"key":"10.4065\/81.5.679_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647265","article-title":"1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia","volume":"64","author":"Casonato","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<158::AID-AJH11>3.0.CO;2-E","article-title":"1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease","volume":"51","author":"McKeown","year":"1996","journal-title":"Am J Hematol"},{"key":"10.4065\/81.5.679_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2516.2004.00886.x","article-title":"Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization","volume":"10","author":"Pasi","year":"2004","journal-title":"Haemophilia"},{"key":"10.4065\/81.5.679_bib44","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1055\/s-0038-1646050","article-title":"Intranasal and intravenous administration of desmopressin: effect on F VIII\/vWF, pharmacokinetics and reproducibility","volume":"58","author":"Lethagen","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.2003.00711.x","article-title":"Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders","volume":"9","author":"United Kingdom Haemophilia Centre Doctors' Organisation","year":"2003","journal-title":"Haemophilia"},{"key":"10.4065\/81.5.679_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2257.2001.00400.x","article-title":"The molecular biology of von Willebrand disease","volume":"23","author":"Keeney","year":"2001","journal-title":"Clin Lab Haematol"},{"key":"10.4065\/81.5.679_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry"},{"key":"10.4065\/81.5.679_bib48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V76.3.555.555","article-title":"Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene","volume":"76","author":"Peake","year":"1990","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib49","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1093\/nar\/19.17.4800","article-title":"Characterisation of 98 alleles in 105 unrelated individuals in the F8VWF gene","volume":"19","author":"Mercier","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.4065\/81.5.679_bib50","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1172\/JCI107465","article-title":"Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation: relationship to factor VIII procoagulant activity and antigen content","volume":"52","author":"Weiss","year":"1973","journal-title":"J Clin Invest"},{"key":"10.4065\/81.5.679_bib51","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor","volume":"66","author":"Mannucci","year":"1985","journal-title":"Blood"},{"issue":"suppl 1","key":"10.4065\/81.5.679_bib52","article-title":"In vitro expression of ten missense mutations in the VWF C-terminal domain identified in patients diagnosed with type 1 VWD: results from the MCMDM-1VWD study [abstract]","volume":"3","author":"Hilbert","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"10.4065\/81.5.679_bib53","article-title":"Two novel type 1 von Willebrand disease causing mutations (G160W and N166I) in the von Willebrand factor propeptide, identified in the European study MCMDM-1VWD, are responsible for multimerization and secretion defects [abstract]","volume":"3","author":"Ribba","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.4065\/81.5.679_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199701000-00001","article-title":"von Willebrand disease","volume":"76","author":"Nichols","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.4065\/81.5.679_bib55","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1055\/s-0037-1614330","article-title":"Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation","volume":"82","author":"Castaman","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib56","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2516.2004.00929.x","article-title":"The genetics of bleeding disorders: a report on the UK Haemophilia Centre Doctors' Organisation annual scientific symposium, 10th October 2003","volume":"10","author":"Nicolle","year":"2004","journal-title":"Haemophilia"},{"key":"10.4065\/81.5.679_bib57","first-page":"850","article-title":"Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I","volume":"51","author":"Zhang","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.4065\/81.5.679_bib58","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0038-1646295","article-title":"Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA","volume":"68","author":"Eikenboom","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib59","doi-asserted-by":"crossref","first-page":"15352","DOI":"10.1073\/pnas.93.26.15352","article-title":"A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11","volume":"93","author":"Mohlke","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/81.5.679_bib60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"MVWF, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"key":"10.4065\/81.5.679_bib61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","article-title":"Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease","volume":"102","author":"O'Brien","year":"2003","journal-title":"Blood"},{"issue":"suppl 1","key":"10.4065\/81.5.679_bib62","article-title":"Linkage analysis of von Willebrand disease type 1 phenotype, von Willebrand factor levels and bleeding symptoms with Von Willebrand factor gene locus in the European Multicenter MCMDM-1VWD study [abstract]","volume":"3","author":"Eikenboom","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.4065\/81.5.679_bib63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.1986.tb02966.x","article-title":"A relatively high frequency of severe (type III) von Willebrand's disease in Israel","volume":"62","author":"Berliner","year":"1986","journal-title":"Br J Haematol"},{"key":"10.4065\/81.5.679_bib64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/1.9.767","article-title":"A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients","volume":"1","author":"Zhang","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.4065\/81.5.679_bib65","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF00206958","article-title":"Genetic heterogeneity of severe von Willebrand disease type III in the German population","volume":"94","author":"Schneppenheim","year":"1994","journal-title":"Hum Genet"},{"key":"10.4065\/81.5.679_bib66","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI112974","article-title":"Gene deletions correlate with the development of alloantibodies in von Willebrand disease","volume":"79","author":"Shelton-Inloes","year":"1987","journal-title":"J Clin Invest"},{"key":"10.4065\/81.5.679_bib67","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"key":"10.4065\/81.5.679_bib68","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V68.6.1207.1207","article-title":"The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors","volume":"68","author":"Batlle","year":"1986","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib69","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V97.7.2059","article-title":"Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease","volume":"97","author":"Schneppenheim","year":"2001","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib71","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0038-1650385","article-title":"Platelet-type von Willebrand disease","volume":"75","author":"Miller","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-0037-1613769","article-title":"Von Willebrand disease type 2M \u201cVicenza\u201d in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families","volume":"83","author":"Schneppenheim","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1650567","article-title":"Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease\u2014results of an international survey","volume":"76","author":"Mazurier","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00210590","article-title":"A novel case of compound heterozygosity with \u201cNormandy\u201d\/type I von Willebrand disease (vWD): direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD","volume":"93","author":"Siguret","year":"1994","journal-title":"Hum Genet"},{"key":"10.4065\/81.5.679_bib76","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2141.2002.03270.x","article-title":"Genotype at the secretor blood group locus is a determinant of plasma von Willebrand factor level","volume":"116","author":"O'Donnell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/81.5.679_bib77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4065\/81.5.679_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.10298","article-title":"Acquired von Willebrand's syndrome: a single institution experience","volume":"72","author":"Kumar","year":"2003","journal-title":"Am J Hematol"},{"key":"10.4065\/81.5.679_bib79","first-page":"345","article-title":"Subcommittee on von Willebrand Factor. Acquired von Willebrand syndrome: data from an international registry [published correction appears in Thromb Haemost. 2000; 84:739]","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"issue":"1, pt 2","key":"10.4065\/81.5.679_bib80","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9378(90)90594-W","article-title":"Hemostasis profile in women taking low-dose oral contraceptives","volume":"163","author":"David","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.4065\/81.5.679_bib81","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib82","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrand's disease or factor XI deficiency","volume":"105","author":"Kadir","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.4065\/81.5.679_bib83","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1991.tb13514.x","article-title":"Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies","volume":"98","author":"Greer","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.4065\/81.5.679_bib84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0038-1647267","article-title":"Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI)","volume":"64","author":"Hansen","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.4065\/81.5.679_bib85","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"10.4065\/81.5.679_bib86","first-page":"2750a","article-title":"Desmopressin use in type 2B von Willebrand disease in North America: a survey of members of the Hemophilia Research Society of North America [abstract]","volume":"100","author":"Kouides","year":"2002","journal-title":"Blood"},{"key":"10.4065\/81.5.679_bib87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00043426-199907000-00009","article-title":"Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature","volume":"21","author":"Kulkarni","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.4065\/81.5.679_bib88","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4065\/77.8.785","article-title":"Primer on medical genomics, part II: background principles and methods in molecular genetics","volume":"77","author":"Tefferi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/81.5.679_bib89","first-page":"240","article-title":"Genetic counseling","volume":"27","year":"1975","journal-title":"Am J Hum Genet"},{"key":"10.4065\/81.5.679_bib90","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1399-0004.2001.600501.x","article-title":"Goals of genetic counseling","volume":"60","author":"Biesecker","year":"2001","journal-title":"Clin Genet"},{"key":"10.4065\/81.5.679_bib91","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4065\/79.5.645","article-title":"Primer on medical genomics, part XIII: ethical and regulatory issues","volume":"79","author":"Hook","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/81.5.679_bib92","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/81.5.679_bib93","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2516.2005.01150.x","article-title":"Management of acquired von Willebrand's syndrome in a patient requiring major surgery","volume":"11","author":"Maddox","year":"2005","journal-title":"Haemophilia"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611617138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611617138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T14:05:01Z","timestamp":1633010701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611617138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0025619611617138"],"URL":"https:\/\/doi.org\/10.4065\/81.5.679","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}